Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of HBV Vaccination Regimens in HIV-infected Adults
NCT02713620Phase 4Completed
- Sponsor
- Chiang Mai University
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine (recombinant) in hepatitis B (HBV), sponsored by Chiang Mai University. Started Jan 2015; status: completed.
02
Drugs
hepatitis b vaccine (recombinant)
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02713620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713620.